menu search

3 biotech stocks poised to beat q2 earnings estimates

We look at a few biotech companies, LEGN, KOD, GRTX, which are poised to beat second-quarter earnings e...

August 14, 2023, 8:39 am

Pds biotechnology: interim data reinforces push towards phase 3 study

PDS Biotechnology has achieved positive results in its phase 2 study of PDS0101 in combination with Merck's Keytruda for HPV16-positive head and neck ...

August 14, 2023, 12:22 am

The prognosis for pds biotechnology

PDS Biotechnology Corporation has had a volatile stock performance in recent years. The company has made slow and steady progress advancing its pipeli...

August 13, 2023, 5:30 am

Avrobio: net-net biotech pursuing strategic alternatives

After monetizing one of its pipeline candidates, Avrobio has cash well in excess of its market cap. The company announced its search for strategic alt...

August 12, 2023, 4:03 am

Jasper therapeutics reports second quarter 2023 financial results and provides a business update

First Patient Dosed in Phase 1 trial of Briquilimab in Lower-Risk Myelodysplastic Syndrome Strengthened the Board of Directors and Management Team wit...

August 11, 2023, 8:05 pm

Kineta reports second quarter 2023 financial results and provides corporate update

Initial Clinical Data Readout from Ongoing Phase 1/2 Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Anticipated by End of 2023 Received $5...

August 11, 2023, 8:01 pm

Aldx stock news: shareholders with significant losses in aldeyra therapeutics, inc. should contact robbins llp

SAN DIEGO, Aug. 11, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchas...

August 11, 2023, 7:11 pm

Benitec biopharma inc. announces closing of $30 million underwritten public offering

HAYWARD, Calif., Aug. 11, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...

August 11, 2023, 5:00 pm

Why shares of biolife solutions plummeted this week

BioLife Solutions focuses on cell- and gene-therapy preservation tools, used primarily by the biotech i...

August 11, 2023, 4:06 pm

biotech bonanza: 3 top dna stocks with revolutionary potential

DNA is as fundamental to biotechnology as it is to biology itself. From synthetic biology to pharmaceuticals, making and using DNA is usually a necess...

August 11, 2023, 1:39 pm

Pliant therapeutics: promising phase 2a bexotegrast data unveiled

Pliant Therapeutics is a biotech company focused on developing therapies for fibrotic diseases. The com...

August 11, 2023, 12:19 pm

Io biotech appoints heidi hunter to its board of directors

NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) — IO biotech (Nasdaq: IOBT), a clinical-stage biopharmaceuti...

August 11, 2023, 12:05 pm

Amrs stock surges 152% as amyris files for bankruptcy

Amyris (NASDAQ: AMRS ) stock is rising higher on Friday with heavy trading after the biotechnology company filed for bankruptcy. AMRS stock is bounci...

August 11, 2023, 10:34 am

Moleculin biotech, inc. (mbrx) q2 2023 earnings call transcript

Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q2 2023 Earnings Call Transcript August 11, 2023 8:30 AM ET Company Participants Jenene Thomas - IR Walter Klem...

August 11, 2023, 10:08 am

Should you invest in the vaneck biotech etf (bbh)?

Looking for broad exposure to the Healthcare - biotech segment of the equity market? You should conside...

August 11, 2023, 7:47 am

Why novavax stock blasted 8% higher today

A coronavirus subvariant is starting to garner more headlines, leading to greater concern about a surge. The b...

August 10, 2023, 6:48 pm

Cidara therapeutics: leveraging antifungals to move into cancer therapy

Cidara Therapeutics is a biotech company with an approved antifungal drug, Rezzayo, but its sales are n...

August 10, 2023, 5:50 pm

Why shares of tango therapeutics skyrocketed this week

Tango increased revenue and reduced net loss in the quarter. The biotech company has several cancer the...

August 10, 2023, 4:52 pm

89bio, inc.: a big bet on nash

89bio, Inc. is a clinical-stage biotech company focused on developing therapies for liver and cardio-me...

August 10, 2023, 1:48 pm

biotech company amyris files for bankruptcy

Synthetic biotechnology company Amyris filed for Chapter 11 bankruptcy protection as it restructures, leading its share price to drop more than 70% in...

August 10, 2023, 11:50 am


Search within

Pages Search Results: